Gene: DCUN1D2
Official Full Name: defective in cullin neddylation 1 domain containing 2provided by HGNC
Gene Summary: Enables cullin family protein binding activity. Involved in positive regulation of protein neddylation. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18367 | DCUN1D2 Knockout cell line (HeLa) | Human | DCUN1D2 | 1:3~1:6 | Negative | Online Inquiry |
KO18368 | DCUN1D2 Knockout cell line (HCT 116) | Human | DCUN1D2 | 1:2~1:4 | Negative | Online Inquiry |
KO18369 | DCUN1D2 Knockout cell line (HEK293) | Human | DCUN1D2 | 1:3~1:6 | Negative | Online Inquiry |
KO18370 | DCUN1D2 Knockout cell line (A549) | Human | DCUN1D2 | 1:3~1:4 | Negative | Online Inquiry |
DCUN1D2 Gene Knockout Cell Lines represent a pivotal advancement in the field of molecular biology, specifically in functional genomics research. These cell lines are engineered to have a complete knockout of the DCUN1D2 gene, a key player in the regulation of various cellular processes, including protein degradation pathways and muscle differentiation. By eliminating the expression of this gene, researchers can examine its role and the downstream effects of its absence, thereby gaining insights into various biological pathways and disease mechanisms.
The key functions of these knockout cell lines facilitate detailed investigations into the DCUN1D2 gene's involvement in cellular responses to stress, development, and potentially oncogenesis. Their mechanism allows scientists to utilize them in assays that assess protein interactions, cellular proliferation, and metabolic activities. By employing techniques such as CRISPR-Cas9 for gene editing, the DCUN1D2 knockout cell lines provide a highly specific and reliable tool for studying gene function and its clinical implications.
The scientific importance of these cell lines is underscored by their applications across multiple research contexts, particularly in cancer research, where understanding the role of genes like DCUN1D2 can unveil novel therapeutic targets. Furthermore, their use in drug discovery initiatives enables the identification of compounds that may interact with the pathways modulated by DCUN1D2, leading to innovative approaches in treatment.
What sets the DCUN1D2 Gene Knockout Cell Lines apart from alternatives is their unparalleled specificity and reliability, ensuring experimental results that are both reproducible and meaningful. With these cell lines, researchers benefit from a streamlined approach to knockout studies, minimizing off-target effects common with less precise methodologies.
For researchers and clinicians keen on advancing their studies into gene function and therapeutic development, the DCUN1D2 Gene Knockout Cell Lines present an invaluable resource. They are designed to enhance experimental robustness, thereby accelerating the translation of findings into practical applications.
Our company specializes in the development and provision of high-quality genetic tools, ensuring that scientists have access to the latest advancements in genetic research, including tailored solutions for specific experimental needs. By leveraging our expertise in gene editing technologies, we are committed to supporting your research initiatives with cutting-edge biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.